|
2-(4-((benzylmethylamino)methyl)benzylidene)-6-(5-diethylaminopentyloxy)-3,4-dihydro-2H-naphthalen-1-one
|
C549965 |
|
|
3-hydroxy-11-oxopregn-17(20)-ene-21-nitrile
|
C560302 |
|
|
2-(4-((benzylmethylamino)methyl)benzylidene)-6-(5-piperidin-1-yl-pentyloxy)-3,4-dihydro-2H-naphthalen-1-one
|
C549966 |
|
|
1,25-dihydroxy-26-(hydroxymethyl)-26-methylvitamin D3
|
C560303 |
|
|
tert-butyl 7-(2-(hydroxyamino)-2-oxoethoxy)-3-(4-methoxyphenylcarbamoyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate
|
C549967 |
|
|
1,25-dihydroxy-26-(hydroxymethyl)vitamin D3
|
C560304 |
|
|
benzyl 7-(2-(hydroxyamino)-2-oxoethoxy)-3-(phenethylcarbamoyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate
|
C549968 |
|
|
LCA5 protein, mouse
|
C560305 |
|
|
2-(2-carboxybenzoylamino)-4-(3'-chloro-4'-fluorobiphenyl-4-yl)thiophene-3-carboxylic acid ethyl ester
|
C549969 |
|
|
p40 protein, Lactobacillus rhamnosus
|
C560306 |
|
|
JMJD2A protein, mouse
|
C560307 |
|
|
MIRN369 microRNA, human
|
C560308 |
|
|
6-bromo-4-allylamino-quinazoline
|
C560309 |
|
|
Ecological Momentary Assessment
|
D000072860 |
[Repeated reports by a research participant of symptoms, affect, behavior, and cognition close in time to experience and in the participant's natural environment.
] |
|
2,3,4,5-tetrahydro-4-(2-chlorophenyl)-2-phenyl-6-(pyrrolidin-1-yl)-1,2,4-triazin-5-one
|
C549970 |
|
|
Phobia, Social
|
D000072861 |
[Anxiety disorder characterized by the persistent and irrational fear, anxiety, or avoidance of social or performance situations.
] |
|
N-(6,6-dimethyl-5-((1-methylpiperidin-4-yl)carbonyl)-1,4,5,6-tetrahydropyrrolo(3,4-c)pyrazol-3-yl)-3-methylbutanamide
|
C549971 |
|
|
N-(5-cyclopropyl-1-(cyclopropylamino)-1,2-dioxopentan-3-yl)-3-(2-(3-(1-((N-cyclopropyl-N-methylsulfamoyl)methyl)cyclohexyl)ureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexane-2-carboxamide
|
C549972 |
|
|
2,6-diisopropylphenol docosahexaenoate
|
C549973 |
|
|
naphthol green B
|
C574940 |
|
